Purpose: The Committee reviews and evaluates data concerning the safety and effectiveness of marketed and investigational in vitro devices for use in clinical laboratory medicine including clinical toxicology, clinical chemistry, endocrinology and oncology and makes appropriate recommendations to the Commissioner of Food and Drugs.
As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.
Current Number of Vacancies: 7
Note, one or more vacancies may be in the nomination process or a final appointment may have been made.
Designated Federal Officer
Patricio G. Garcia, M.P.H.
Commander, US Public Health Service
Center for Devices and Radiological Health
Office of Management
10903 New Hampshire Avenue
WO Bldg. 66 Rm 5216
Silver Spring, Maryland 20993
Office: (301) 796-6875
Fax: (301) 847-8505
George Grunberger, M.D., F.A.C.P.
Expertise: Endocrinology; Metabolism
Term: 03/01/2018 – 02/28/2022
Grunberger Diabetes Institute
43494 Woodward Avenue Suite 208
Bloomfield Hills, MI 48302
Ann M. Quinn, BSMT, RAC**
Term: 02/27/2019 – 02/28/2023
Worldwide Director, Regulatory Affairs
Ortho-Clinical Diagnostics, Inc.
100 Indigo Cree Drive
Rochester, NY 14626
* Consumer Representative
** Industry Representative